News Inspira Technologies Oxy B.H.N. Ltd.

Equities

IINN

IL0011715781

Real-time Estimate Cboe BZX Other stock markets 12:16:34 2024-04-29 pm EDT			5-day change	1st Jan Change
1.875 ^USD	-0.79%		+0.50%	+80.14%

Apr. 17	Inspira Technologies OXY B.H.N. Ltd Signs Collaboration Term Sheet with the Beilinson Hospital in Israel for the Evaluation of Its Proprietary INSPIRA ART100 device in Organ Transplant Procedures	CI
Apr. 16	Inspira, Beilinson Hospital Collaborate on Organ Transplant Device Evaluation	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Inspira Technologies OXY B.H.N. Ltd Signs Collaboration Term Sheet with the Beilinson Hospital in Israel for the Evaluation of Its Proprietary INSPIRA ART100 device in Organ Transplant Procedures	Apr. 17	CI
Inspira, Beilinson Hospital Collaborate on Organ Transplant Device Evaluation	Apr. 16	MT
Inspira?? and Ennocure In Vitro Study Results Show 100% Prevention of Bacterial Growth Causes Bloodstream Infections	Apr. 10	CI
Inspira? Technologies Oxy B.H.N. Ltd. Announces Program to Pioneer the Applicable Use of the INSPIRA? ART100 Device for an Artificial Womb	Apr. 03	CI
Inspira Announces $1.65 Million Registered Direct Offering of Ordinary Shares by Inspira CEO's Mother with Leading Fund Manager	Apr. 02	AQ
Inspira Technologies Reports Full Year 2023 Financial Results	Mar. 26	AQ
Inspira Technologies Oxy B.H.N. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 25	CI
Inspira Technologies OXY B.H.N. Ltd. Announces AMAR Regulatory Submission of the INSPIRA? ART100, to Enter the Southeast Asia and South American Markets	Mar. 18	CI
Inspira Releases New Data Demonstrating Superiority of its Core Technology, Across Key Endpoints of HMSS Indicator	Mar. 12	CI
INSPIRA TECHNOLOGIES OXY B H N : NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS - Form 6-K	Mar. 08	PU
INSPIRA TECHNOLOGIES OXY B H N : NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS - Form 6-K	Mar. 04	PU
Inspira Technologies Oxy B.H.N. Ltd. Plans to Report the Primary Results for A Core Blood Oxygenation Technology Within Days	Mar. 04	CI
Inspira Announces Breakthrough Update, Nears First FDA 510(k) Approval, 3 U.S. Patents Approved, $546 million in Summary Distribution Agreements	Feb. 28	AQ
Inspira to Host Conference Call to Discuss Investor Presentation and Announce Next Major Milestone	Feb. 28	AQ
Inspira Technologies Oxy B.H.N. Ltd. Announces Approval from the U.S. Food & Drug Administration for its INSPIRA ART100 in the First Half of 2024	Feb. 27	CI
Inspira Technologies OXY B.H.N. Ltd. Introduces High-End Platform for Bio-Mimicking Blood parameters for Development and Testing of Core Technologies	Feb. 22	CI
Inspira Receives First Ever U.S. Patent Approval for an Orbiting Blood Oxygenation Delivery System	Feb. 15	AQ
Sector Update: Health Care Stocks Gain Late Afternoon	Feb. 14	MT
Sector Update: Health Care Stocks Rise in Afternoon Trading	Feb. 14	MT
Sector Update: Health Care	Feb. 14	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Inspira Technologies Oxy B.H.N. Ltd.

Equities

IINN

IL0011715781

Summary

Filters